Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM CL A
Number of holders
40
Total Shares
5.39M
Shares change
-1.08M
Total reported value, excl. options
$10.8M
Value change
-$2.21M
Put/Call ratio
0.05
Number of buys
21
Number of sells
-11
Price
$2.02
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.